# Spok Holdings, Inc: financial statements, quarterly

SPOK · Nasdaq · CIK 1289945 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/spok.md) · [Financials](/companies/spok/financials.md) · [Filings](/companies/spok/filings.md) · [Insiders](/companies/spok/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/spok/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.0 d](/filings/0001289945-26-000010.md) | [34.9](/filings/0001289945-25-000025.md) | [34.0](/filings/0001289945-25-000044.md) | [34.9](/filings/0001289945-25-000057.md) | [33.9 d](/filings/0001289945-26-000010.md) | [36.3](/filings/0001289945-26-000027.md) | [35.7](/filings/0001289945-26-000050.md) | [33.9](/filings/0001289945-26-000063.md) | [33.9 d](/filings/0001289945-26-000010.md) | [33.2](/filings/0001289945-26-000027.md) | [35.0](/filings/0001289945-26-000050.md) | [33.0](/filings/0001289945-26-000063.md) |
| Cost of revenue | $m | [7.2 d](/filings/0001289945-26-000010.md) | [7.1](/filings/0001289945-25-000025.md) | [7.2](/filings/0001289945-25-000044.md) | [7.1](/filings/0001289945-25-000057.md) | [7.3 d](/filings/0001289945-26-000010.md) | [7.3](/filings/0001289945-26-000027.md) | [7.4](/filings/0001289945-26-000050.md) | [7.4](/filings/0001289945-26-000063.md) | [7.7 d](/filings/0001289945-26-000010.md) | [7.7](/filings/0001289945-26-000027.md) | [6.8](/filings/0001289945-26-000050.md) | [6.7](/filings/0001289945-26-000063.md) |
| Research and development | $m | [2.8 d](/filings/0001289945-26-000010.md) | [3.0](/filings/0001289945-25-000025.md) | [3.2](/filings/0001289945-25-000044.md) | [2.8](/filings/0001289945-25-000057.md) | [2.7 d](/filings/0001289945-26-000010.md) | [3.1](/filings/0001289945-26-000027.md) | [3.1](/filings/0001289945-26-000050.md) | [3.0](/filings/0001289945-26-000063.md) | [3.0 d](/filings/0001289945-26-000010.md) | [3.5](/filings/0001289945-26-000027.md) | [3.3](/filings/0001289945-26-000050.md) | [3.2](/filings/0001289945-26-000063.md) |
| Operating income | $m | [4.1 d](/filings/0001289945-26-000010.md) | [4.9](/filings/0001289945-25-000025.md) | [4.5](/filings/0001289945-25-000044.md) | [5.0](/filings/0001289945-25-000057.md) | [4.6 d](/filings/0001289945-26-000010.md) | [6.0](/filings/0001289945-26-000027.md) | [5.4](/filings/0001289945-26-000050.md) | [4.4](/filings/0001289945-26-000063.md) | [3.9 d](/filings/0001289945-26-000010.md) | [2.4](/filings/0001289945-26-000027.md) | [5.4](/filings/0001289945-26-000050.md) | [5.6](/filings/0001289945-26-000063.md) |
| Income tax | $m | [1.0 d](/filings/0001289945-26-000010.md) | [0.9](/filings/0001289945-25-000025.md) | [1.4](/filings/0001289945-25-000044.md) | [1.5](/filings/0001289945-25-000057.md) | [1.2 d](/filings/0001289945-26-000010.md) | [1.1](/filings/0001289945-26-000027.md) | [1.8](/filings/0001289945-26-000050.md) | [1.4](/filings/0001289945-26-000063.md) | [1.3 d](/filings/0001289945-26-000010.md) | [0.6](/filings/0001289945-26-000027.md) | [1.5](/filings/0001289945-26-000050.md) | [3.6](/filings/0001289945-26-000063.md) |
| Net income | $m | [3.4 d](/filings/0001289945-26-000010.md) | [4.2](/filings/0001289945-25-000057.md) | [3.4](/filings/0001289945-25-000057.md) | [3.7](/filings/0001289945-25-000057.md) | [3.6 d](/filings/0001289945-26-000010.md) | [5.2](/filings/0001289945-26-000063.md) | [4.6](/filings/0001289945-26-000063.md) | [3.2](/filings/0001289945-26-000063.md) | [2.9 d](/filings/0001289945-26-000010.md) | [2.0](/filings/0001289945-26-000063.md) | [4.1](/filings/0001289945-26-000063.md) | [9.7](/filings/0001289945-26-000063.md) |
| Diluted EPS | $ per share | not reported | [0.21](/filings/0001289945-25-000025.md) | [0.17](/filings/0001289945-25-000044.md) | [0.18](/filings/0001289945-25-000057.md) | not reported | [0.25](/filings/0001289945-26-000027.md) | [0.22](/filings/0001289945-26-000050.md) | [0.15](/filings/0001289945-26-000063.md) | not reported | [0.09](/filings/0001289945-26-000027.md) | [0.20](/filings/0001289945-26-000050.md) | [0.46](/filings/0001289945-26-000063.md) |
| Basic EPS | $ per share | not reported | [0.21](/filings/0001289945-25-000025.md) | [0.17](/filings/0001289945-25-000044.md) | [0.18](/filings/0001289945-25-000057.md) | not reported | [0.25](/filings/0001289945-26-000027.md) | [0.22](/filings/0001289945-26-000050.md) | [0.16](/filings/0001289945-26-000063.md) | not reported | [0.10](/filings/0001289945-26-000027.md) | [0.20](/filings/0001289945-26-000050.md) | [0.46](/filings/0001289945-26-000063.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.0](/filings/0001289945-25-000008.md) | [23.3](/filings/0001289945-24-000032.md) | [23.9](/filings/0001289945-24-000048.md) | [27.8](/filings/0001289945-24-000061.md) | [29.1](/filings/0001289945-26-000010.md) | [19.9](/filings/0001289945-25-000025.md) | [20.2](/filings/0001289945-25-000044.md) | [21.4](/filings/0001289945-25-000057.md) | [25.3](/filings/0001289945-26-000063.md) | [17.1](/filings/0001289945-26-000027.md) | [16.6](/filings/0001289945-26-000050.md) | [30.1](/filings/0001289945-26-000063.md) |
| Current assets | $m | [63.9](/filings/0001289945-25-000008.md) | [52.9](/filings/0001289945-24-000032.md) | [56.1](/filings/0001289945-24-000048.md) | [58.4](/filings/0001289945-24-000061.md) | [61.3](/filings/0001289945-26-000010.md) | [50.4](/filings/0001289945-25-000025.md) | [56.5](/filings/0001289945-25-000044.md) | [59.5](/filings/0001289945-25-000057.md) | [57.9](/filings/0001289945-26-000063.md) | [47.2](/filings/0001289945-26-000027.md) | [50.6](/filings/0001289945-26-000050.md) | [57.2](/filings/0001289945-26-000063.md) |
| Total assets | $m | [228](/filings/0001289945-25-000008.md) | [215](/filings/0001289945-24-000032.md) | [216](/filings/0001289945-24-000048.md) | [217](/filings/0001289945-24-000061.md) | [217](/filings/0001289945-26-000010.md) | [204](/filings/0001289945-25-000025.md) | [209](/filings/0001289945-25-000044.md) | [210](/filings/0001289945-25-000057.md) | [206](/filings/0001289945-26-000063.md) | [194](/filings/0001289945-26-000027.md) | [196](/filings/0001289945-26-000050.md) | [198](/filings/0001289945-26-000063.md) |
| Current liabilities | $m | [48.0](/filings/0001289945-25-000008.md) | [39.9](/filings/0001289945-24-000032.md) | [43.4](/filings/0001289945-24-000048.md) | [45.6](/filings/0001289945-24-000061.md) | [48.8](/filings/0001289945-26-000010.md) | [40.8](/filings/0001289945-25-000025.md) | [45.4](/filings/0001289945-25-000044.md) | [49.1](/filings/0001289945-25-000057.md) | [49.1](/filings/0001289945-26-000063.md) | [43.4](/filings/0001289945-26-000027.md) | [46.3](/filings/0001289945-26-000050.md) | [44.3](/filings/0001289945-26-000063.md) |
| Total liabilities | $m | [63.9](/filings/0001289945-25-000008.md) | [54.8](/filings/0001289945-24-000032.md) | [58.2](/filings/0001289945-24-000048.md) | [60.5](/filings/0001289945-24-000061.md) | [62.4](/filings/0001289945-26-000010.md) | [52.7](/filings/0001289945-25-000025.md) | [57.7](/filings/0001289945-25-000044.md) | [61.0](/filings/0001289945-25-000057.md) | [59.7](/filings/0001289945-26-000063.md) | [52.9](/filings/0001289945-26-000027.md) | [55.7](/filings/0001289945-26-000050.md) | [53.8](/filings/0001289945-26-000063.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [164](/filings/0001289945-26-000010.md) | [160](/filings/0001289945-25-000057.md) | [158](/filings/0001289945-25-000057.md) | [156](/filings/0001289945-25-000057.md) | [155](/filings/0001289945-26-000063.md) | [152](/filings/0001289945-26-000063.md) | [151](/filings/0001289945-26-000063.md) | [149](/filings/0001289945-26-000063.md) | [146](/filings/0001289945-26-000063.md) | [141](/filings/0001289945-26-000063.md) | [140](/filings/0001289945-26-000063.md) | [145](/filings/0001289945-26-000063.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.8 d](/filings/0001289945-26-000010.md) | [2.0](/filings/0001289945-25-000025.md) | [7.4 d](/filings/0001289945-25-000044.md) | [11.1 d](/filings/0001289945-25-000057.md) | [8.4 d](/filings/0001289945-26-000010.md) | [2.3](/filings/0001289945-26-000027.md) | [7.0 d](/filings/0001289945-26-000050.md) | [8.1 d](/filings/0001289945-26-000063.md) | [11.5 d](/filings/0001289945-26-000010.md) | [2.4](/filings/0001289945-26-000027.md) | [6.5 d](/filings/0001289945-26-000050.md) | [13.0 d](/filings/0001289945-26-000063.md) |
| Capital expenditure | $m | [1.0 d](/filings/0001289945-26-000010.md) | [0.9](/filings/0001289945-25-000025.md) | [0.6 d](/filings/0001289945-25-000044.md) | [0.8 d](/filings/0001289945-25-000057.md) | [0.9 d](/filings/0001289945-26-000010.md) | [0.7](/filings/0001289945-26-000027.md) | [1.0 d](/filings/0001289945-26-000050.md) | [0.6 d](/filings/0001289945-26-000063.md) | [1.4 d](/filings/0001289945-26-000010.md) | [0.6](/filings/0001289945-26-000027.md) | [0.6 d](/filings/0001289945-26-000050.md) | [0.7 d](/filings/0001289945-26-000063.md) |
| Dividends paid | $m | [6.2 d](/filings/0001289945-26-000010.md) | [7.4](/filings/0001289945-25-000025.md) | [6.3 d](/filings/0001289945-25-000044.md) | [6.3 d](/filings/0001289945-25-000057.md) | [6.3 d](/filings/0001289945-26-000010.md) | [7.9](/filings/0001289945-26-000027.md) | [6.5 d](/filings/0001289945-26-000050.md) | [6.4 d](/filings/0001289945-26-000063.md) | [6.4 d](/filings/0001289945-26-000010.md) | [8.0](/filings/0001289945-26-000027.md) | [6.5 d](/filings/0001289945-26-000050.md) | [6.5 d](/filings/0001289945-26-000063.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.2](/filings/0001289945-24-000032.md) | [20.3](/filings/0001289945-24-000048.md) | [20.3](/filings/0001289945-24-000061.md) | [20.4](/filings/0001289945-25-000025.md) | [20.5](/filings/0001289945-25-000044.md) | [20.5](/filings/0001289945-25-000057.md) | [20.7](/filings/0001289945-26-000027.md) | [20.8](/filings/0001289945-26-000050.md) | [21.0](/filings/0001289945-26-000063.md) | [21.1](/filings/0001289945-26-000027.md) | [21.1](/filings/0001289945-26-000050.md) | [21.2](/filings/0001289945-26-000063.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,930,052 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001289945-26-000063.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:22 ET. No prices; not investment advice.